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1. Introduction
We are glad to share with you our fourth Journal Club and highlight some of the most interesting
papers published recently. We hope to help keep you aware of non-coding RNA research outside of
your area. The Non-Coding RNA Scientific Board wishes you an exciting and fruitful read.
2. Disruptive RNA-Seq Bioinformatics
Highlight by Daniel Gautheret
Quantifying gene expression from RNA-Sequencing (RNA-Seq) data used to be a settled matter.
Nearly all protocols would start with “Step 1: align sequence reads onto a reference genome”.
This process required days of computer time and access to powerful servers, even for a basic
experimental setup. As RNA-Seq projects grew larger in scale, running this analysis started to turn
into a bioinformatician's nightmare. This is now changing radically thanks to efforts by two US-based
groups. Their new programs, Kallisto [1] and Salmon [2], are based on hashing, a method that converts
a sequence file into an index of words of fixed size (k-mers). Comparing an RNA-Seq library to an
entire transcriptome at the k-mer level now takes minutes instead of hours. Both programs implement
procedures to resolve ambiguities (k-mers matching several transcripts) and assign a read count to
each transcript, achieving a precision in transcript abundance estimation comparable to that of the best
mapping-based methods. Not only are Salmon and Kallisto as accurate and an order of magnitude
faster than the current software, but they are also more flexible, as they enable the quantification of
independent transcripts as well as whole gene expression. The non-coding RNA community should
take note.
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3. Cytoplasmic lncRNA Mediates HIF-Targeted Enzymatic Cascade
Highlight by Joseph H. Taube and Sendurai A. Mani
The potential functions of long non-coding RNAs, which were first established as nuclear
regulators of gene expression, are expanding to include cytoplasmic roles. In an elegant blend of
biochemistry, cell biology, and cancer biology, Lin, et al. [3] show that LINK-A (long intergenic
non-coding RNA for kinase activation) functions in the cytoplasm by binding and altering the
conformation of protein tyrosine kinase 6 (also known as breast tumor kinase, BRK). By recruiting
a second kinase, Leucine-rich repeat kinase 2 (LRRK2), and by interacting with BRK at two separate
domains to alter its conformation, LINK-A facilitates the phosphorylation and nuclear translocation of
Hypoxia-inducible factor 1-alpha (HIF-1α), despite normoxic conditions. Notably, the expression of
LINK-A and the activation of HIF-1α signaling is not only enriched in triple-negative breast cancer
but is also predictive of poor recurrence-free survival in triple-negative breast cancer (TNBC) patients.
Importantly, blocking LINK-A via shRNA compromises tumor growth, thus opening the door for
lncRNA-targeted therapy.
4. Microbiome and microRNAs Mediate the Communication Between Gut and Vasculature
Highlight by Gaetano Santulli
The gut microbiome has been implicated in the pathogenesis of endothelial dysfunction and
atherosclerosis. Ajit Vikram and colleagues have elegantly identified one of the mechanisms underlying
such a connection in microRNAs (miRs) [4]. In particular, the authors found that the expression of
miR-204 in the vascular wall is remotely upregulated by the microbiome in mice. One of the targets
of miR-204 is Sirtuin1 (Sirt1), a class II histone deacetylase that stimulates endothelial nitric oxide
synthase (eNOS), which is essential for the maintenance of a normal vascular tone [5]. Intriguingly,
a high-fat diet upregulated miR-204 in the aorta and the suppression of gut flora biomass resulted in
a significant decrease in vascular miR-204 and an increase in the expression of Sirt1, with a general
amelioration of endothelial function.
This discovery has major implications given the acknowledged importance of diet in the
pathogenesis of cardiovascular disease [6]. Moreover, the authors have left the door open for the
identification of the mediators responsible for the remote communication between the gut and vessels,
suggesting a potential role for serum factors.
5. Stable Intronic Sequence RNAs (sisRNAs) Regulate Their Cognate Pre-mRNAs
Highlight by Diego Cuerda-Gil and R. Keith Slotkin
Typical intron RNAs are rapidly degraded after they are spliced from their pre-mRNA. A new
class of “stable intronic sequence RNAs (sisRNAs)” has been recently identified, that do not degrade
and rather accumulate in the nucleus. SisRNAs are produced from human cell lines, introns of
the Epstein-Barr virus, and Xenopus tropicalis oocytes, but they have poorly understood functions.
Pek et al. [7] identified 34 candidate sisRNAs from Drosophila melanogaster embryos. They focused
on one sisRNA, sisR-1, produced from the regena (rga) locus. Their data suggests that sisR-1
regulates a negative feedback loop influencing protein production from this locus. This function
is mediated through the repression of a natural antisense transcript (called ASTR) produced from
the rga locus. The authors propose that sisR-1 plays a critical role in the nucleus by repressing ASTR
accumulation during embryogenesis, and therefore increases the robustness of rga protein production.
Deeper characterization and understanding of sisRNAs are needed, including the determination of
whether sisRNAs are evolutionary conserved.
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6. Structural Study of CRISPR-Cpf1 Still on the Road
Highlight by Bo Zhang and Yanli Wang
Cpf1 is a newly identified single RNA-guide endonuclease of a class 2 type V CRISPR-Cas system.
It has been successfully utilized to manipulate the human genome [8–10]. Recently, two kinds of
crystal structures of Cpf1 have been reported [11–13]. In the LbCpf1-crRNA binary complex, the
overall structure has a triangle-shape and a bilobed architecture. The repeat region of the crRNA
forms a pseudoknot structure recognized by the WED and RuvC domains of Cpf1, whereas the
spacer region is invisible in the binary complex. In the AsCfp1-crRNA-DNA ternary complex, the
RNA-DNA heteroduplex is bound within the positively charged central channel, formed by the REC
lobe and the NUC lobe. Structural comparison revealed that the REC lobe is significantly rearranged
to accommodate the RNA-DNA heteroduplex, and that the PAM-interacting cleft undergoes a modest
open-to-closed transition upon the PAM duplex binding. However, the cleavage mechanism of Cpf1
mediated target DNA cleavage still needs further studies.
7. Ionizing Radiation Gets miRNAs Excited
Highlight by David W. Salzman and Joanne B. Weidhaas
MicroRNA (miRNA) expression is regulated by several mechanisms, including transcription and
processing, to generate a mature miRNA that is loaded into miRISC, which exacts gene silencing. It is
widely accepted that miRNA expression is directly correlated with its gene silencing activity. However,
in a recent Nature Communications article, Salzman et al. discovered that there is a pool of mature
miR-34 in cells devoid of activity, lacking a canonical 5′-end phosphate, and is not loaded into miRISC.
After DNA damage, this miR-34 is 5′-end phosphorylated through the DNA damage sensor ATM and
the RNA kinase Clp1, thereby loading miR-34 into miRISC and activating it. Knockdown experiments
differentiated two distinct miR-34 activation pathways following DNA damage. One pathway occurs
via ATM/Clp1 activation and the other by TP53-mediated transcription. The ATM/Clp1-dependent
pathway rapidly suppressed miR-34 target genes (CDK4 and BCL2) several hours ahead of TP53
transcription, which sustains miR-34 activity over time.
These findings highlight a discordance in miRNA expression and activity, and elucidate a novel
mechanism for the activation of miRNA activity in response to an external stimulus. Numerous reports
show that miRNA expression can be altered by external stimuli (environmental changes, growth
factors, cell stress, drug treatment, etc.), and these findings raise questions about what the pre-stimulus
pool of miRNAs in these systems are doing. Furthermore, this work supports the potential importance
of miR-34 targeting to enhance radiation therapy in cancer patients [14].
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